acrolein has been researched along with Ventricular Dysfunction, Left in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cascio, WE; Farraj, AK; Haykal-Coates, N; Hazari, MS; Ledbetter, AD; Thompson, LC | 1 |
| Bhatnagar, A; Chandrasekar, B; Gu, Y; Haberzettl, P; Hamid, T; Ismahil, MA; Prabhu, SD; Srivastava, S | 1 |
| Bhatnagar, A; Cai, J; Gu, Y; Hill, BG; Luo, J; Prabhu, SD; Srivastava, S | 1 |
3 other study(ies) available for acrolein and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Acrolein Inhalation Alters Myocardial Synchrony and Performance at and Below Exposure Concentrations that Cause Ventilatory Responses.
Topics: Acrolein; Air Pollutants; Animals; Cardiotoxicity; Dose-Response Relationship, Drug; Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed; Inhalation Exposure; Lung; Male; Mice, Inbred C57BL; Myocardial Contraction; Plethysmography, Whole Body; Pneumonia; Pulmonary Ventilation; Risk Assessment; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy.
Topics: Acrolein; Administration, Oral; Animals; Apoptosis; Cardiomyopathy, Dilated; Environmental Pollutants; Gene Expression Regulation; Hypertrophy, Left Ventricular; Immunohistochemistry; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocarditis; Myocardium; Oxidative Stress; Real-Time Polymerase Chain Reaction; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure.
Topics: Acetylcysteine; Acrolein; Aldehydes; Animals; Antioxidants; Calcium Signaling; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Environmental Exposure; Environmental Pollutants; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Oxidative Stress; Protein Carbonylation; Proteomics; Risk Assessment; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfhydryl Compounds; Ventricular Dysfunction, Left; Ventricular Pressure | 2007 |